FDC Performance
- Today's Low
- ₹427
- Today's High
- ₹437
- 52 Week Low
- ₹313
- 52 Week High
- ₹528
- Open Price₹435
- Previous Close₹434
- Volume208,480
- 50 DMA₹390.76
- 100 DMA₹386.22
- 200 DMA₹397.85
FDC Chart
Investment Returns
- Over 1 Month + 8.78%
- Over 3 Month + 30.17%
- Over 6 Month + 3.4%
- Over 1 Year -11.07%
Smart Investing Starts Here Start SIP with FDC for Steady Growth!
FDC Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.1
- PEG Ratio
- 4.6
- Market Cap Cr
- 7,063
- P/B Ratio
- 2.8
- Average True Range
- 14.32
- EPS
- 18.24
- Dividend Yield
- 1.2
- MACD Signal
- 9.52
- RSI
- 70.46
- MFI
- 90.63
Latest Stock News Updates
Pharmaceuticals company FDC announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: Reported at Rs 58,478.71 lakh for Q4FY26, reflecting a growth of 18.89% YoY (compared to Rs 49,188.93 lakh in Q4FY25) and 25.84% QoQ (compared to Rs 46,470.77 lakh in Q3FY26). For FY26, revenue stood at Rs 2,17,093.32 lakh, an increase of 2.94% YoY compared to Rs 2,10,812.04 lakh in FY25. Net Profit After Tax: Reported at Rs 10,339.67 lakh for Q4FY26, an increase of 167.37% YoY (compared to Rs 3,867.13 lakh in Q4FY25) and 265.33% QoQ (compared to Rs 2,830.26 lakh in Q3FY26). For FY26, net profit stood at Rs 28,142.16 lakh, up 5.48% YoY from Rs 26,678.81 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: Reported at Rs 56,436.37 lakh for Q4FY26, up 17.09% YoY (compared to Rs 48,200.43 lakh in Q4FY25) and 23.24% QoQ (compared to Rs 45,794.05 lakh in Q3FY26). For FY26, revenue was Rs 2,12,632.72 lakh, a growth of 2.71% YoY over Rs 2,07,011.19 lakh in FY25. Net Profit After Tax: Reported at Rs 10,707.03 lakh for Q4FY26, an increase of 122.07% YoY (compared to Rs 4,821.55 lakh in Q4FY25) and 293.83% QoQ (compared to Rs 2,718.71 lakh in Q3FY26). For FY26, net profit was Rs 28,592.34 lakh, an increase of 4.49% YoY compared to Rs 27,362.60 lakh in FY25. Business Highlights: Segment Performance: The company operates in a single segment, namely "Pharmaceuticals". Auditor Appointments: The Board approved the re-appointment of M/s. GMVP & Associates LLP as Cost Auditor for FY27. The Board approved the re-appointment of M/s. Ford, Rhodes, Parks & Co., Chartered Accountants, as the Tax Auditor for FY27. Management Appointments: The Board approved the appointment of Mr. K. Achyutanand Reddy as the Company Secretary & Compliance Officer, effective May 26, 2026. Result PDF
- Trendlyne
- 1 month 1 week ago
The differentiation was against the backdrop of a FSSAI directive disallowing companies from using the ORS (Oral Rehydration Salts) label on beverages, as part of their trademark
- Business Line
- 2 months 3 weeks ago
The move aims to ensure compliance with drug regulations and prevent risks associated with unapproved medicines, with authorities asked to submit an urgent action taken report.
- Business Line
- 3 months 1 week ago
FDC Financials
FDC Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹407.00
- 50 Day
- ₹390.80
- 100 Day
- ₹386.20
- 200 Day
- ₹397.80
Resistance and Support
- R3 447.93
- R2 442.47
- R1 438.13
- S1 428.33
- S2 422.87
- S3 418.53
FDC Corporate Actions - Bonus, Splits, Dividends
About FDC
- NSE Symbol
- FDC
- BSE Symbol
- 531599
- Managing Director
- Mr. Mohan A Chandavarkar
- ISIN
- INE258B01022
Similar Stocks to FDC
Popular Stocks
FDC FAQs
FDC share price is ₹433 As on 04 July, 2026 | 22:27
The Market Cap of FDC is ₹7062.7 Cr As on 04 July, 2026 | 22:27
The P/E ratio of FDC is 25.1 As on 04 July, 2026 | 22:27
The PB ratio of FDC is 2.8 As on 04 July, 2026 | 22:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.